Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HECT, UBA and WWE domain containing 1 (HUWE1) is a large E3 ubiquitin-protein ligase belonging to the HECT family, which plays a central role in maintaining cellular protein homeostasis (UniProt Q7Z6Z7). It functions by tagging specific substrate proteins with ubiquitin chains, marking them for degradation by the 26S proteasome. HUWE1 is involved in a wide array of biological processes, including the DNA damage response, cell cycle regulation, and apoptosis, by targeting key proteins such as the anti-apoptotic factor MCL1, the oncoprotein MYC, and the tumor suppressor p53 (PMID: 15958491, 28218735). Due to its ability to regulate both oncogenic and tumor-suppressive pathways, its role in cancer is highly context-dependent and varies across different tissue types. Beyond its implications in oncology, mutations in the HUWE1 gene are a known cause of X-linked intellectual disability and other neurodevelopmental disorders (PMID: 27535533). In the realm of drug development, HUWE1 is being investigated as a target for small-molecule inhibitors and as a recruited ligase for targeted protein degradation via molecular glues like BI-3802 (PMID: 32555461). However, the broad spectrum of its cellular targets presents significant challenges regarding therapeutic specificity and potential systemic toxicity.
Targeted protein degradation via recruitment of the HUWE1 E3 ligase to specific substrates (e.g., BCL6) or direct inhibition of the HECT domain catalytic activity to stabilize tumor suppressors (PMID: 32555461, 28218735).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HECT, UBA and WWE domain containing 1 (HUWE1) (HUWE1).